Is a complete RXRX research report available?

No complete published report is available for Recursion Pharmaceuticals, Inc. (RXRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · USD

$4.35

+0.29 (+7.3%)· Recorded snapshot

Market cap	2.6B
Revenue (ttm)	54.9M
Net income (ttm)	-518.9M
EPS (ttm)	-$1.02
Shares out	597.8M
Volume	26,871,879
Beta	1.03

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 54.9M
Net income (ttm): -518.9M
EPS (ttm): -$1.02
Market cap: 2.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001601830
Company name	Recursion Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	75629V104
Earnings date	2026-11-02
Earnings time	bmo
Employees	600
Employees change	-200
Employees growth	-25%
Enterprise value	$2.1B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-04-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US75629V1044
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.6B
Market cap category	Mid-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$4.35
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	RXRX
Tags	artificial-intelligence
U.S. state	Utah
Website	https://www.recursion.com

Metric

Value

Amount currency

USD

CIK code

0001601830

Company name

Recursion Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

75629V104

Earnings date

2026-11-02

Earnings time

bmo

Employees

600

Employees change

-200

Employees growth

-25%

Enterprise value

$2.1B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2013

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-04-16

Is primary listing

Yes

Is SPAC

ISIN number

US75629V1044

Last 10-K release date

2026-02-25

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2.6B

Market cap category

Mid-Cap

Next earnings date

2026-11-02

Options

Yes

Price

$4.35

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

RXRX

Tags

artificial-intelligence

U.S. state

Utah

Website

https://www.recursion.com

Metric	Value
Earnings yield	-23.52%
EV/Sales	37.58x
FCF / EV yield	-17.09%
FCF yield	-13.87%
Forward EV/Sales	35.73x
Forward P/S	44.03x
P/B ratio	2.37x
P/S ratio	46.32x
Price / tangible book value	5.39x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-23.52%

EV/Sales

37.58x

FCF / EV yield

-17.09%

FCF yield

-13.87%

Forward EV/Sales

35.73x

Forward P/S

44.03x

P/B ratio

2.37x

P/S ratio

46.32x

Price / tangible book value

5.39x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-1,002.56%
Pretax margin	-954.25%
Profit per employee	$-864,807
Revenue per employee	$91,427
ROA	-27.33%
ROA (5Y)	-27.41%
ROCE	-50.33%
ROE	-56.58%
ROE (5Y)	-56.93%
ROIC	-34.57%
SBC / revenue	165.38%
Tax / revenue	-8.35%

Metric

Value

Operating margin

-1,002.56%

Pretax margin

-954.25%

Profit per employee

$-864,807

Revenue per employee

$91,427

ROA

-27.33%

ROA (5Y)

-27.41%

ROCE

-50.33%

ROE

-56.58%

ROE (5Y)

-56.93%

ROIC

-34.57%

SBC / revenue

165.38%

Tax / revenue

-8.35%

Metric	Value
EPS growth quarters	3
EPS growth years	1
Net income growth quarters	3
Net income growth years	0
Revenue growth	-15.08%
Revenue growth (Q)	-60.1%
Revenue growth (QoQ)	18.51%
Revenue growth 3Y	3.15%
Revenue growth 5Y	44.11%
Revenue growth years	6

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-15.08%

Revenue growth (Q)

-60.1%

Revenue growth (QoQ)

18.51%

Revenue growth 3Y

3.15%

Revenue growth 5Y

44.11%

Revenue growth years

Metric	Value
Capital expenditures	$-1.8M
Depreciation and amortization	$78.4M
EBIT	$-550M
EBITDA	$-471.6M
EPS	$-1.02
FCF per share	$-0.59
Financing cash flow	$378.6M
Free cash flow	$-352.3M
Free cash flow minus SBC	$-443M
Gross profit	$-392.6M
Income taxes	$-4.6M
Investing cash flow	$-6.1M
Net borrowing	$-8.8M
Net cash flow	$23M
Net income	$-518.9M
Operating cash flow minus SBC	$-441.2M
Operating income	$-550M
Revenue	$54.9M
Stock-based compensation	$90.7M

Metric

Value

Capital expenditures

$-1.8M

Depreciation and amortization

$78.4M

EBIT

$-550M

EBITDA

$-471.6M

EPS

$-1.02

FCF per share

$-0.59

Financing cash flow

$378.6M

Free cash flow

$-352.3M

Free cash flow minus SBC

$-443M

Gross profit

$-392.6M

Income taxes

$-4.6M

Investing cash flow

$-6.1M

Net borrowing

$-8.8M

Net cash flow

$23M

Net income

$-518.9M

Operating cash flow minus SBC

$-441.2M

Operating income

$-550M

Revenue

$54.9M

Stock-based compensation

$90.7M

Metric	Value
Altman Z-Score	0.61
Book value per share	$1.71
Debt / equity	0.07
Goodwill	$160.4M
Interest coverage	-371.35
Long-term assets	$609.2M
Long-term liabilities	$177.8M
Net cash (debt)	$479M
Net cash / market cap	18.85%
Net cash growth	9.61%
Net debt / equity	-0.52
Piotroski F-Score	3
Property, plant and equipment	$147.1M
Shareholders' equity	$915M
Tangible book value	$471.8M
Tangible book value per share	$0.88
Total assets	$1.2B
Total cash	$545.7M
Total debt	$66.6M
Total liabilities	$297.7M
WACC	9.72%

Metric

Value

Altman Z-Score

0.61

Book value per share

$1.71

Debt / equity

0.07

Goodwill

$160.4M

Interest coverage

-371.35

Long-term assets

$609.2M

Long-term liabilities

$177.8M

Net cash (debt)

$479M

Net cash / market cap

18.85%

Net cash growth

9.61%

Net debt / equity

-0.52

Piotroski F-Score

Property, plant and equipment

$147.1M

Shareholders' equity

$915M

Tangible book value

$471.8M

Tangible book value per share

$0.88

Total assets

$1.2B

Total cash

$545.7M

Total debt

$66.6M

Total liabilities

$297.7M

WACC

9.72%

Metric	Value
Asset turnover	0.04
Current assets	$603.5M
Current liabilities	$119.9M
Current ratio	5.03
Net working capital	$-39.4M
Quick ratio	4.67
Working capital	$483.6M
Working capital turnover	0.12

Metric

Value

Asset turnover

0.04

Current assets

$603.5M

Current liabilities

$119.9M

Current ratio

5.03

Net working capital

$-39.4M

Quick ratio

4.67

Working capital

$483.6M

Working capital turnover

0.12

Metric	Value
Buyback yield / dilution	-41.13%
Dividend yield	0%
Shareholder yield	-41.13%

Metric

Value

Buyback yield / dilution

-41.13%

Dividend yield

Shareholder yield

-41.13%

Metric	Value
150-day SMA	$3.43
1D price change	7.28%
1M price change	16.18%
1M total return	16.18%
1W price change	19.37%
1W total return	19.37%
1Y price change	-31.03%
1Y return CAGR	-31.05%
1Y total return	-31.03%
20-day SMA	$3.99
200-day SMA	$3.53
3M price change	44.35%
3M total return	44.35%
3Y price change	-17.71%
3Y return CAGR	-6.29%
3Y total return	-17.71%
50-day SMA	$3.72
50-day SMA vs 200-day SMA	50over200
52-week high	$6.25
52-week high date	2025-10-28
52-week low	$2.77
52-week low date	2026-05-19
5Y price change	-76.95%
5Y return CAGR	-25.44%
5Y total return	-76.95%
6M price change	24.86%
6M total return	24.86%
All-time high	$42.81
All-time high date	2021-07-13
All-time low	$2.77
All-time low date	2026-05-19
Average true range (ATR)	$0.35
Average volume	31M
Beta (1Y)	2.59
Beta (2Y)	3.15
Beta (5Y)	1.03
Change from 52-week high	-30.48%
Change from 52-week low	56.86%
Change from all-time high	-89.85%
Change from all-time low	56.86%
Change from open	8.35%
Day's gap	-0.99%
Dollar volume	$116.8M
High price	$4.43
Low price	$4.00
Monthly RSI	44.74
Open price	$4.01
Position in 52-week range	81.4%
Premarket change	-1.23%
Premarket close	$4.05
Premarket price	$4.00
Premarket volume	169.8K
Previous close	$4.05
Price vs 150-day SMA	26.53%
Price vs 20-day SMA	8.92%
Price vs 200-day SMA	22.98%
Price vs 50-day SMA	16.93%
Relative volume	0.88
Return from IPO open	-85.83%
Return from IPO price	-76.39%
RSI	59.07
Sharpe ratio	-0.2
Sharpe ratio (3Y)	0.27
Sharpe ratio (5Y)	0.09
Sortino ratio	-0.21
Sortino ratio (3Y)	0.49
Sortino ratio (5Y)	0.21
Volume	26.9M
Weekly RSI	57.69
YTD price change	6.24%
YTD total return	6.24%

Metric

Value

150-day SMA

$3.43

1D price change

7.28%

1M price change

16.18%

1M total return

16.18%

1W price change

19.37%

1W total return

19.37%

1Y price change

-31.03%

1Y return CAGR

-31.05%

1Y total return

-31.03%

20-day SMA

$3.99

200-day SMA

$3.53

3M price change

44.35%

3M total return

44.35%

3Y price change

-17.71%

3Y return CAGR

-6.29%

3Y total return

-17.71%

50-day SMA

$3.72

50-day SMA vs 200-day SMA

50over200

52-week high

$6.25

52-week high date

2025-10-28

52-week low

$2.77

52-week low date

2026-05-19

5Y price change

-76.95%

5Y return CAGR

-25.44%

5Y total return

-76.95%

6M price change

24.86%

6M total return

24.86%

All-time high

$42.81

All-time high date

2021-07-13

All-time low

$2.77

All-time low date

2026-05-19

Average true range (ATR)

$0.35

Average volume

31M

Beta (1Y)

2.59

Beta (2Y)

3.15

Beta (5Y)

1.03

Change from 52-week high

-30.48%

Change from 52-week low

56.86%

Change from all-time high

-89.85%

Change from all-time low

56.86%

Change from open

8.35%

Day's gap

-0.99%

Dollar volume

$116.8M

High price

$4.43

Low price

$4.00

Monthly RSI

44.74

Open price

$4.01

Position in 52-week range

81.4%

Premarket change

-1.23%

Premarket close

$4.05

Premarket price

$4.00

Premarket volume

169.8K

Previous close

$4.05

Price vs 150-day SMA

26.53%

Price vs 20-day SMA

8.92%

Price vs 200-day SMA

22.98%

Price vs 50-day SMA

16.93%

Relative volume

0.88

Return from IPO open

-85.83%

Return from IPO price

-76.39%

RSI

59.07

Sharpe ratio

-0.2

Sharpe ratio (3Y)

0.27

Sharpe ratio (5Y)

0.09

Sortino ratio

-0.21

Sortino ratio (3Y)

0.49

Sortino ratio (5Y)

0.21

Volume

26.9M

Weekly RSI

57.69

YTD price change

6.24%

YTD total return

6.24%

Metric	Value
Float	580.9M
Float percentage	97.18%
Shares change (QoQ)	0.6%
Shares change (YoY)	41.13%
Shares held by insiders	2.67%
Shares held by institutions	61.26%
Shares outstanding	597.8M
Short % of float	27.19%
Short % of shares	26.42%
Short ratio	7.8 days

Metric

Value

Float

580.9M

Float percentage

97.18%

Shares change (QoQ)

0.6%

Shares change (YoY)

41.13%

Shares held by insiders

2.67%

Shares held by institutions

61.26%

Shares outstanding

597.8M

Short % of float

27.19%

Short % of shares

26.42%

Short ratio

7.8 days

Metric	Value
Page views	236

Metric

Value

Page views

236

Recursion Pharmaceuticals, Inc. (RXRX)

Price

Financial snapshot

Fair-value bridge

Latest news · RXRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RXRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on RXRX

Frequently asked questions